På dette tidspunkt bør behandlingen genoptages med en dosis svarende til cirka 25% under den forrige administrerede dosis.
If the haemoglobin level continues to increase, therapy should be interrupted until the hemoglobin level begins to decrease, at which point therapy should be restarted at a dose approximately 25% below the previously administered dose.